New York Metropolitan Transportation Authority (MTA) Chairman and CEO Patrick J. Foye sent warning letters to MTA’s 11 largest suppliers on Sept. 17. “The COVID-19 pandemic has exacted a horrific toll in human, social and economic terms across the nation,” he noted in the letters. “I am writing to alert you that because of this financial devastation, many current and all future contracts are in jeopardy without an injection of $12 billion in emergency federal aid.”
New York MTA
Starting Monday, Sept. 14, New York’s Metropolitan Transportation Authority (MTA) will issue a $50 fine to any rider who refuses to wear a mask on New York City subways and buses, Metro-North Railroad (MNR), and the Long Island Rail Road (LIRR). This follows New York Gov. Andrew M. Cuomo’s executive order on Thursday, Sept. 10, directing the MTA to develop a plan to increase mask compliance.
There are always two sides to every story. I don’t have the financial resources to hire an army of public relations people to ghost write columns like New York MTA Chairman Pat Foye has and send them to every media outlet in town. Nevertheless, here’s my take on an alarmist op-ed that recently appeared in the New York Times, re-printed by Railway Age.
New York Metropolitan Transportation Authority Chairman Pat Foye has been consistently outspoken in his criticism of President Trump and the Federal Highway Administration concerning obtaining permission from Washington to begin congestion pricing in Manhattan. Foye and others blame both the President and FHWA for continued delays in advancement of the federal NEPA Environmental Review process. The MTA has been waiting for guidance to determine if congestion pricing implementation will need a less-detailed Environmental Assessment or more complex Environmental Impact Statement.
Who has been minding the mint after learning about the latest New York Metropolitan Transportation Authority example of potential waste, fraud and abuse? It’s Interim MTA New York City Transit President Sarah Feinberg, who after only four months on the job revealed that her operating agency has been functioning with an incomplete organization chart.
Fitch Ratings has assigned a rating of “A+” to approximately $600 million of Transportation Revenue Bonds (TRB) Series 2020D (Mandatory Tender Bonds) and a rating of “F1” to $500 million of transportation revenue Series 2020B Bond Anticipation Notes (BANs) to be issued by the New York Metropolitan Transportation Authority. The bonds and BANs will be sold via negotiation; the sale date and principal amount are both subject to market conditions. Proceeds will finance existing approved transit and commuter projects. Fitch has affirmed at “A+” approximately $24.4 billion of outstanding TRBs. The Rating Outlook is Negative.
Sally Librera, the first woman appointed MTA New York City Transit Senior Vice President Subways, has resigned, effective July 24.
According to a report in THE CITY, the New York MTA is expected to announce that a 60-day hold on capital projects announced in March will remain in place while the transit agency tries to secure another $3.9 billion in emergency federal funding.
The Metropolitan Transportation Authority (MTA) has expanded its partnership with Northwell Health-GoHealth and BioReference Laboratories to provide antibody testing for all MTA employees throughout the New York metropolitan region at no cost.
If you are looking to understand of the history of New York City Transit’s Second Avenue Subway, read “Last Subway, The Long Wait for the Next Train in New York City” by Philip Mark Plotch. The author clearly did his research on the subject. The book explains in detail why progress has been so slow for construction of the long-anticipated Second Avenue Subway.